Kodiak Sciences Inc. (KOD)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 12
in 63 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About Kodiak Sciences Inc.
Kodiak Sciences Inc. is a clinical-stage Biotechnology company listed on NASDAQ under KOD that focuses on treatments for retinal disease. The company is dedicated to discovering, advancing, and bringing to market therapies for conditions affecting the retina, and it remains in the clinical development phase.
Today's Snapshot
Yesterday KOD fell 3.7% to 33.78.
Trading Volume
Above 10d avg 574.5K
643.5K
vs S&P 500 Today
Strong Underperformance
-3.20%
Updated: September 10, 2026 at 12:26 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$32.16 - $38.89Sell
- RSI (14)31.38Neutral
- Stochastic %K (14, 3, 3)6.06Buy
- MACD Level (12, 26)-1.54Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.